Chargement en cours...
"Flagellated" cancer cells propel anti-tumor immunity
The use of innate immune receptor agonists in cancer therapies has suffered from many drawbacks. Our recent observations suggest that some of these hurdles can be overcome by introducing flagellin into tumor cells to promote tumor antigen presentation by dendritic cells (DCs) and simultaneously trig...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Landes Bioscience
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3489752/ https://ncbi.nlm.nih.gov/pubmed/23162764 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.20305 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|